Anti-N-methyl-D-aspartate receptor encephalitis during treatment with adalimumab for psoriasis

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e591-e593. doi: 10.1111/jdv.16456. Epub 2020 May 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / drug therapy
  • Female
  • Humans
  • Ovarian Neoplasms*
  • Psoriasis* / drug therapy
  • Teratoma*

Substances

  • Adalimumab